Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer02:18

Cancer

53.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
53.6K
What is Cancer?02:12

What is Cancer?

14.0K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
14.0K
Cancer Prevention02:59

Cancer Prevention

7.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.7K
Cancer Therapies02:49

Cancer Therapies

9.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Cancer Vaccines01:30

Cancer Vaccines

984
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
984
Skin Cancer01:30

Skin Cancer

5.7K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Inflammatory stress-induced amino acid transformation generates diabetogenic T cells.

Nature immunology·2026
Same author

Discontinuous template switching generates coronavirus subgenomic RNAs from the 3' viral genome end by 5' to 3' transcription.

Journal of virology·2025
Same author

Nanoscopy Reveals Heparan Sulfate Clusters as Docking Sites for SARS-CoV-2 Attachment and Entry.

bioRxiv : the preprint server for biology·2025
Same author

Translon: a single term for translated regions.

Nature methods·2025
Same author

High binding potency overcomes the requirement of Fc effector functions for broadly reactive anti-alphavirus antibodies.

Science translational medicine·2025
Same author

A two-step mechanism for RIG-I activation by influenza virus mvRNAs.

Science advances·2025

相关实验视频

Updated: Jan 22, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K

在MHC一二拳中,击败了癌症.

Amir Ghorbani1, Jonathan W Yewdell1

  • 1Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases , Bethesda, MD, USA.

The Journal of experimental medicine
|January 20, 2026
PubMed
概括

研究人员开发了完整的T细胞抗原 (CTA),将多个化成一个分子. 这种新的方法显著提高了癌症免疫疗法的疗效,即使没有瘤抗原表达.

科学领域:

  • 免疫学 免疫学 免疫学
  • 在瘤学瘤学.
  • 生物技术是生物技术.

背景情况:

  • 癌症免疫疗法旨在利用免疫系统消除瘤.
  • 目前的策略经常面临抗原呈现和瘤特异性的挑战.
  • T细胞在适应性免疫力对抗癌症方面发挥着至关重要的作用.

研究的目的:

  • 引入一种名为完整T细胞抗原 (CTA) 的新疗法概念.
  • 评估CTAs在提高癌症免疫疗法的有效性方面的潜力.
  • 调查CTA是否可以改善T细胞反应,即使瘤细胞没有表达标抗原.

主要方法:

  • 通过融合I类和II类免疫性来设计和合成完整的T细胞抗原 (CTA).
  • 在体外和体内研究,以评估T细胞激活和抗瘤活性.
  • 在不同瘤抗原表达水平的背景下分析免疫反应.

主要成果:

  • 由I类和II类质组成的CTAs已成功开发出来.
  • 这些CTA表明,癌症免疫疗法的有效性显著增加.
  • 即使在瘤细胞中没有表达CTA抗原时,也观察到增强的T细胞反应,这表明更广泛的适用性.

更多相关视频

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

15.1K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

10.3K

相关实验视频

Last Updated: Jan 22, 2026

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.6K
Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis
09:32

Immunopeptidomics: Isolation of Mouse and Human MHC Class I- and II-Associated Peptides for Mass Spectrometry Analysis

Published on: October 15, 2021

15.1K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on: February 28, 2019

10.3K

结论:

  • 完整的T细胞抗原代表了癌症免疫疗法的有希望的进步.
  • CTA提供了一种策略,以克服与瘤抗原表达有关的局限性.
  • 这种方法有可能改善更广泛的癌症患者的治疗结果.